Cargando…
Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future
In contrast to the wealth of proven therapies for heart failure with reduced ejection fraction (HFrEF), therapeutic efforts in the past have failed to improve outcomes in heart failure with preserved ejection fraction (HFpEF). Moreover, to this day, diagnosis of HFpEF remains controversial. However,...
Autores principales: | Wintrich, Jan, Kindermann, Ingrid, Ukena, Christian, Selejan, Simina, Werner, Christian, Maack, Christoph, Laufs, Ulrich, Tschöpe, Carsten, Anker, Stefan D., Lam, Carolyn S. P., Voors, Adriaan A., Böhm, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449942/ https://www.ncbi.nlm.nih.gov/pubmed/32236720 http://dx.doi.org/10.1007/s00392-020-01633-w |
Ejemplares similares
-
Management strategies in heart failure with preserved ejection fraction
por: Wintrich, Jan, et al.
Publicado: (2022) -
Reply to ‘Heart failure with preserved ejection fraction and COVID‐19: which comes first, the chicken or the egg?’
por: Anker, Markus S., et al.
Publicado: (2021) -
Heart-Focused Anxiety, General Anxiety, Depression and Health-Related Quality of Life in Patients with Atrial Fibrillation Undergoing Pulmonary Vein Isolation
por: Pavlicek, Valérie, et al.
Publicado: (2022) -
Phosphodiesterase 4 inhibition but not beta-adrenergic stimulation suppresses tumor necrosis factor-alpha release in peripheral blood mononuclear cells in septic shock
por: Link, Andreas, et al.
Publicado: (2008) -
New Insights in (Inter)Cellular Mechanisms by Heart Failure with Preserved Ejection Fraction
por: Tschöpe, Carsten, et al.
Publicado: (2014)